Found 8 matching trials
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
PHASE3In this study, an investigational medication named BXCL501 is being tested ...
Location
BioXcel Clinical Research Site 113
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
PHASE3This is a definitive study to support the safety and efficacy evaluation of...
Location
BioXcel Clinical Research Site
Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder
PHASE2This open-label study will utilize treatment with BXCL501 in order to asses...
Location
BioXcel Clinical Research Site 103
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
PHASE1This is a two-stage adaptive Phase Ib trial design, that will identify two ...
Location
BioXcel Clinical Research Site
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
PHASE3This is a definitive study to support the safety and efficacy evaluation of...
Location
BioXcel Clinical Research Site
Study of BXCL501 In Agitation Associated With Delirium in ICU Patients
PHASE2This study is designed to determine and evaluate the optimal BXCL501 starti...
Location
BioXcel Clinical Research Site
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
PHASE1This is a study of the efficacy and safety of BXCL501 in children and adole...
Location
BioXcel Clinical Research Site
Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal
PHASE1This Phase 1b/2 inpatient study assessed the safety, pharmacokinetics, and ...
Location
BioXcel Clinical Research Site